Article
Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
Frontiers in immunology - 1 Jan 2021
Li Aifen, Guo Fengbiao, Pan Quanren, Chen Shuxian, Chen Jiaxuan, Liu Hua-Feng, Pan Qingjun
Abstract excerpt
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Although previous studies have demonstrated that SLE is related to the imbalance of cells in the immune system, including B cells, T cells, and dendritic cells, etc., the mechanisms underlying SLE pathogenesis remain unclear. Therefore, effective and low side-effect therapies for SLE are lacking. Recently, mesenchymal stem cell (MSC) therapy for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
